IL-15 is a novel cytokine with potent T cell growth factor activity. H
ere, we investigated the role of IL-15 in the human immune response to
intracellular infection by studying patients leprosy. We found that I
L-15 mRNA and protein were more strongly expressed in immunologically
resistant tuberculoid patients than in with unresponsive and susceptib
le lepromatous patients. In vitro, Mycobacterium leprae induced IL-15
secretion from peripheral blood monocytes. Furthermore, rIL-15 by itse
lf and in combination with rIL-2 or rlL-7 augmented PBMC proliferative
responses to the pathogen. Although rIL-15 expanded the CD3(-)CD56(+)
(NK) subset, rIL-15 combined with M. leprae induced the expansion of
CD3(+)CD56(+) T cells. Immunohistologic analysis of leprosy skin lesio
ns indicated that the frequency of CD56(+) cells was greatest in the g
roup of patients with high IL-15 expression, and that >90% of the CD56
(+) cells in lesions were CD3(+) T cells. Therefore, IL-15 augments th
e local T cell response to human intracellular pathogen.